{"id":123902,"date":"2026-06-19T14:45:29","date_gmt":"2026-06-19T09:15:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=123902"},"modified":"2026-06-19T14:45:30","modified_gmt":"2026-06-19T09:15:30","slug":"why-is-krebs-biochemicals-and-industries-share-price-falling","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/","title":{"rendered":"Why Is Krebs Biochemicals and Industries Share Price Falling Key Reasons 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Krebs Biochemicals and Industries share price is down 10% from Rs 71 to Rs 64 in 2026. FII selling, earnings pressure and valuation de-rating drive the decline.<\/em><\/p>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/krebsbio\/krebs-biochemicals-and-industries-ltd-share-price-today\">Krebs Biochemicals and Industries<\/a> share price falling<\/strong> trend has become a key investor concern in 2026. The stock has declined approximately 10 percent from its 52 week high of Rs 71 to current levels near Rs 64, prompting investors to ask whether this correction represents a buying opportunity or signals deeper structural challenges. Krebs Biochemicals and Industries (NSE: KREBSBIO), listed in the Pharmaceutical API Manufacturing space, has witnessed sustained selling pressure through FY26. Understanding the <strong>Krebs Biochemicals and Industries share price falling<\/strong> narrative requires careful analysis of both company-specific headwinds and the broader macro forces at work in 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#About_Krebs_Biochemicals_and_Industries\" title=\"About Krebs Biochemicals and Industries\">About Krebs Biochemicals and Industries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Why_Is_Krebs_Biochemicals_and_Industries_Share_Price_Falling_Key_Reasons\" title=\"Why Is Krebs Biochemicals and Industries Share Price Falling: Key Reasons\">Why Is Krebs Biochemicals and Industries Share Price Falling: Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#1_FII_Selling_and_Broad_Market_Correction\" title=\"1. FII Selling and Broad Market Correction\">1. FII Selling and Broad Market Correction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#2_Sector-Specific_Headwinds_in_Pharmaceutical_API_Manufacturing\" title=\"2. Sector-Specific Headwinds in Pharmaceutical API Manufacturing\">2. Sector-Specific Headwinds in Pharmaceutical API Manufacturing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#3_Earnings_Deceleration_and_Margin_Compression\" title=\"3. Earnings Deceleration and Margin Compression\">3. Earnings Deceleration and Margin Compression<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#4_Valuation_De-Rating_from_Peak_Multiples\" title=\"4. Valuation De-Rating from Peak Multiples\">4. Valuation De-Rating from Peak Multiples<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#5_Small_and_Mid_Cap_Liquidity_Squeeze\" title=\"5. Small and Mid Cap Liquidity Squeeze\">5. Small and Mid Cap Liquidity Squeeze<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#6_Global_Macroeconomic_Uncertainty\" title=\"6. Global Macroeconomic Uncertainty\">6. Global Macroeconomic Uncertainty<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Financial_Performance_Analysis_of_Krebs_Biochemicals_and_Industries\" title=\"Financial Performance Analysis of Krebs Biochemicals and Industries\">Financial Performance Analysis of Krebs Biochemicals and Industries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Technical_Signals_What_the_Charts_Are_Saying\" title=\"Technical Signals What the Charts Are Saying\">Technical Signals What the Charts Are Saying<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Can_Krebs_Biochemicals_and_Industries_Share_Price_Recover\" title=\"Can Krebs Biochemicals and Industries Share Price Recover\">Can Krebs Biochemicals and Industries Share Price Recover<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Why_is_Krebs_Biochemicals_and_Industries_share_price_falling_in_2026\" title=\"Why is Krebs Biochemicals and Industries share price falling in 2026?\">Why is Krebs Biochemicals and Industries share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#What_is_the_52_week_high_and_low_of_Krebs_Biochemicals_and_Industries\" title=\"What is the 52 week high and low of Krebs Biochemicals and Industries?\">What is the 52 week high and low of Krebs Biochemicals and Industries?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#Should_I_buy_Krebs_Biochemicals_and_Industries_shares_at_current_levels\" title=\"Should I buy Krebs Biochemicals and Industries shares at current levels?\">Should I buy Krebs Biochemicals and Industries shares at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#What_are_the_recovery_triggers_for_Krebs_Biochemicals_and_Industries_share_price_falling\" title=\"What are the recovery triggers for Krebs Biochemicals and Industries share price falling?\">What are the recovery triggers for Krebs Biochemicals and Industries share price falling?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#What_are_the_key_downside_risks_to_Krebs_Biochemicals_and_Industries_share_price_falling\" title=\"What are the key downside risks to Krebs Biochemicals and Industries share price falling?\">What are the key downside risks to Krebs Biochemicals and Industries share price falling?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-krebs-biochemicals-and-industries-share-price-falling\/#What_is_the_market_cap_of_Krebs_Biochemicals_and_Industries\" title=\"What is the market cap of Krebs Biochemicals and Industries?\">What is the market cap of Krebs Biochemicals and Industries?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Krebs_Biochemicals_and_Industries\"><\/span><strong>About Krebs Biochemicals and Industries<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharmaceutical API manufacturer. Circuit range Rs 57.88 to Rs 70.74. Revenue Rs 100 crore. CMP Rs 64, down 10 percent from upper circuit. The stock is currently trading at approximately Rs 64, down 10 percent from its 52 week high of Rs 71. The 52 week low is Rs 58, and the market cap stands at approximately Rs 500 crore.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>KREBSBIO<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical API Manufacturing<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 64<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 71<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 58<\/td>\n<\/tr>\n<tr>\n<td>Decline from 52W High<\/td>\n<td>Approximately 10 percent<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 500 crore (approx)<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>20x<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_Krebs_Biochemicals_and_Industries_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Krebs Biochemicals and Industries Share Price Falling: Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_FII_Selling_and_Broad_Market_Correction\"><\/span><strong>1. FII Selling and Broad Market Correction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The dominant external driver behind the <strong>Krebs Biochemicals and Industries share price falling<\/strong> is the sustained FII selling wave that swept Indian equities through FY26. The US reciprocal tariff announcement imposing a 26 percent levy on Indian goods triggered a broad risk-off selloff, causing FIIs to pull significant capital from Indian equity markets. The 10 percent correction from the 52 week peak reflects the combined impact of macro-level FII selling and company-specific headwinds operating simultaneously in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Sector-Specific_Headwinds_in_Pharmaceutical_API_Manufacturing\"><\/span><strong>2. Sector-Specific Headwinds in Pharmaceutical API Manufacturing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Beyond the broad market decline, the Pharmaceutical API Manufacturing sector faced its own challenges in FY26. Analyst earnings estimates were revised downward as input cost inflation, competitive pricing pressures and demand moderation weighed on sector outlook. This sector de-rating contributed meaningfully to the <strong>Krebs Biochemicals and Industries share price falling<\/strong> trend as institutional investors reduced overall sector exposure, leading to broad-based price declines across the peer group.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Earnings_Deceleration_and_Margin_Compression\"><\/span><strong>3. Earnings Deceleration and Margin Compression<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A key company-specific factor behind the <strong>Krebs Biochemicals and Industries share price falling<\/strong> is the deceleration in earnings growth relative to the elevated expectations baked in at the 52 week high of Rs 71. Revenue and profitability came under pressure from input cost inflation, competitive pricing constraints and higher operating costs. The market is now recalibrating to a more moderate growth trajectory, triggering a meaningful re-rating of the stock from peak levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Valuation_De-Rating_from_Peak_Multiples\"><\/span><strong>4. Valuation De-Rating from Peak Multiples<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At its 52 week high of Rs 71, Krebs Biochemicals and Industries was trading at valuation multiples above its historical average. As quarterly results came in below peak expectations and sector sentiment turned cautious, the market applied lower multiples to the company&#8217;s earnings. This valuation de-rating from Rs 71 to Rs 64 is one of the primary mechanical drivers of the <strong>Krebs Biochemicals and Industries share price falling<\/strong> by 10 percent in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Small_and_Mid_Cap_Liquidity_Squeeze\"><\/span><strong>5. Small and Mid Cap Liquidity Squeeze<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With a market cap of approximately Rs 500 crore, Krebs Biochemicals and Industries is exposed to the liquidity dynamics of the small and mid cap segment, which experienced a sharp squeeze in FY25-26. This liquidity effect has amplified the <strong>Krebs Biochemicals and Industries share price falling<\/strong> trend beyond what fundamentals alone would suggest, as thinner order books convert moderate selling into outsized price declines.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"6_Global_Macroeconomic_Uncertainty\"><\/span><strong>6. Global Macroeconomic Uncertainty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s equity market in FY26 faced macro headwinds including global tariff wars, crude oil price volatility and currency pressure, which collectively dampened institutional risk appetite. This macro overhang reinforced the <strong>Krebs Biochemicals and Industries share price falling<\/strong> pressure by keeping buyers cautious even when individual company fundamentals did not fully justify the magnitude of the sell-off.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Financial_Performance_Analysis_of_Krebs_Biochemicals_and_Industries\"><\/span><strong>Financial Performance Analysis of Krebs Biochemicals and Industries<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key metrics driving the <strong>Krebs Biochemicals and Industries share price falling<\/strong> narrative are visible across both quarterly earnings trends and valuation levels. The stock has fallen 10 percent from Rs 71 to Rs 64, with the market cap contracting to approximately Rs 500 crore. Investors should closely monitor upcoming quarterly results and management commentary on revenue recovery and margin trajectory as the primary near-term catalyst for any price stabilisation.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Key Metric<\/th>\n<th>Current Level<\/th>\n<th>52 Week Peak<\/th>\n<th>Trend<\/th>\n<\/tr>\n<tr>\n<td>Share Price<\/td>\n<td>Rs 64<\/td>\n<td>Rs 71<\/td>\n<td>Down 10 percent<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 500 crore<\/td>\n<td>Higher at 52W peak<\/td>\n<td>Compressed<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>20x<\/td>\n<td>Higher at 52W high<\/td>\n<td>Multiple compressed<\/td>\n<\/tr>\n<tr>\n<td>52 Week Range<\/td>\n<td colspan=\"3\">Rs 58 to Rs 71<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen Krebs Biochemicals and Industries and compare with peers on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Signals_What_the_Charts_Are_Saying\"><\/span><strong>Technical Signals What the Charts Are Saying<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Technically, the stock is trading below its 50 day, 100 day and 200 day simple moving averages, all of which are sloping downward. Since the 52 week high of Rs 71, Krebs Biochemicals and Industries has formed a clear pattern of lower highs and lower lows. Key support is at the 52 week low of Rs 58, while overhead resistance sits at the Rs 71 zone. <em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and get daily expert stock picks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Can_Krebs_Biochemicals_and_Industries_Share_Price_Recover\"><\/span><strong>Can Krebs Biochemicals and Industries Share Price Recover<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Despite the headwinds driving the <strong>Krebs Biochemicals and Industries share price falling<\/strong> trend, genuine recovery catalysts exist. Any positive inflection in the Pharmaceutical API Manufacturing sector driven by improved macro conditions or policy support could trigger a sharp re-rating. A quarterly earnings result beating the now-lowered analyst expectations could also catalyse a short-covering rally from oversold levels. A broader recovery in small and mid cap market sentiment as FII flows normalise post the tariff shock would lift Krebs Biochemicals and Industries stock alongside the broader peer group. At Rs 64, a significant portion of the bad news may already be priced in, creating a potentially attractive entry point for investors with a 2 to 3 year horizon. At current levels, the risk-reward for the <strong>Krebs Biochemicals and Industries share price falling<\/strong> thesis may be increasingly asymmetric in favour of patient long-term buyers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Krebs Biochemicals and Industries share price falling<\/strong> by approximately 10 percent from Rs 71 to Rs 64 reflects broad market headwinds, FII selling, earnings deceleration and valuation de-rating in the Pharmaceutical API Manufacturing sector. A sustainable reversal will require a clear improvement in quarterly financial momentum and a more constructive macro environment. Investors tracking the <strong>Krebs Biochemicals and Industries share price falling<\/strong> trend should monitor upcoming earnings results, any shifts in FII ownership and macro developments closely before making any fresh position decisions. For real-time data on Krebs Biochemicals and Industries, visit Univest.<\/p>\n<p style=\"background: #C0392B; color: #fff; font-weight: bold; padding: 12px 16px; border-radius: 4px;\"><strong>Disclaimer Note:<\/strong> Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Data sourced from publicly available open sources. SEBI Registration No. INH000013776.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Krebs_Biochemicals_and_Industries_share_price_falling_in_2026\"><\/span><strong>Why is Krebs Biochemicals and Industries share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Krebs Biochemicals and Industries share price falling trend in 2026 is driven by FII selling triggered by the US tariff announcement, sector headwinds in the Pharmaceutical API Manufacturing space, earnings deceleration and valuation de-rating from peak multiples. The stock has declined approximately 10% from its 52 week high of Rs 71 to the current Rs 64.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Krebs_Biochemicals_and_Industries\"><\/span><strong>What is the 52 week high and low of Krebs Biochemicals and Industries?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Krebs Biochemicals and Industries is Rs 71 and the 52 week low is Rs 58. The current price of approximately Rs 64 represents a decline of about 10% from the 52 week high, placing the stock in correction territory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_buy_Krebs_Biochemicals_and_Industries_shares_at_current_levels\"><\/span><strong>Should I buy Krebs Biochemicals and Industries shares at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether to invest in Krebs Biochemicals and Industries at Rs 64 depends on your investment horizon and risk appetite. The stock has corrected 10% from its peak, which may improve the risk-reward for long-term investors. Always consult a SEBI registered financial advisor before any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_recovery_triggers_for_Krebs_Biochemicals_and_Industries_share_price_falling\"><\/span><strong>What are the recovery triggers for Krebs Biochemicals and Industries share price falling?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key recovery catalysts for Krebs Biochemicals and Industries include quarterly earnings beating reduced analyst expectations, reversal of FII selling as global macro conditions improve, positive sector re-rating in the Pharmaceutical API Manufacturing space and a broader small and mid cap market recovery in India.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_downside_risks_to_Krebs_Biochemicals_and_Industries_share_price_falling\"><\/span><strong>What are the key downside risks to Krebs Biochemicals and Industries share price falling?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include continued earnings estimate downgrades, further FII selling if global risk appetite remains weak, unexpected regulatory or competitive developments in the Pharmaceutical API Manufacturing sector and a deeper market correction that could push the stock toward its 52 week low of Rs 58.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Krebs_Biochemicals_and_Industries\"><\/span><strong>What is the market cap of Krebs Biochemicals and Industries?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current market capitalisation of Krebs Biochemicals and Industries is approximately Rs 500 crore based on the prevailing price of Rs 64. This represents a significant compression from peak levels, reflecting the broader correction in the stock through 2026.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Why is Krebs Biochemicals and Industries share price falling? Key reasons behind the decline from Rs 71 to Rs 64, financial analysis and what investors should watch in 2026.<\/p>\n","protected":false},"author":35,"featured_media":124201,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-123902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781860533:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_seo_score":["78"],"rank_math_title":["Why Is Krebs Biochemicals and Industries Share Price Falling Key Reasons 2026"],"rank_math_description":["Why is Krebs Biochemicals and Industries share price falling? Key reasons behind the decline from Rs 71 to Rs 64, financial analysis and what investors should watch in 2026."],"rank_math_focus_keyword":["Krebs Biochemicals and Industries share price falling"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"rank_math_primary_category":["842"],"_thumbnail_id":["124201"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["19507"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Why-Is-Krebs-Biochemicals-and-Industries-Share-Price-Falling-Key-Reasons-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/123902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=123902"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/123902\/revisions"}],"predecessor-version":[{"id":124202,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/123902\/revisions\/124202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/124201"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=123902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=123902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=123902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}